Premium
Simultaneous determination of a drug candidate and its metabolite in rat plasma samples using ultrafast monolithic column high‐performance liquid chromatography/tandem mass spectrometry
Author(s) -
Hsieh Yunsheng,
Wang Gangfeng,
Wang Yuguang,
Chackalamannil Samuel,
Brisson JeanMarc,
Ng Kwokei,
Korfmacher Walter A.
Publication year - 2002
Publication title -
rapid communications in mass spectrometry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.528
H-Index - 136
eISSN - 1097-0231
pISSN - 0951-4198
DOI - 10.1002/rcm.648
Subject(s) - chromatography , chemistry , metabolite , monolithic hplc column , high performance liquid chromatography , mass spectrometry , bioanalysis , tandem mass spectrometry , liquid chromatography–mass spectrometry , resolution (logic) , biochemistry , artificial intelligence , computer science
Abstract An ultrafast bioanalytical method using monolithic column high‐performance liquid chromatography/tandem mass spectrometry (HPLC/MS/MS) was evaluated for the simultaneous determination of a drug discovery compound and its metabolite in plasma. Baseline separation of the two compounds was achieved with run times of 24 or 30 s under isocratic or gradient conditions, respectively. The monolithic column HPLC/MS/MS system offers shorter chromatographic run times by increasing flow rate without sacrificing separation power for the drug candidate and its biotransformation product (metabolite). In this work, the necessity for adequate chromatographic resolution was demonstrated because the quantitative determination of the drug‐related metabolism product was otherwise hampered by interference from the dosed drug compound. The chromatographic performance of a monolithic silica rod column as a function of HPLC flow rates was investigated with a mixture of the drug component and its synthetic metabolite. The assay reliability of the monolithic column HPLC/MS/MS system was checked for matrix ionization suppression using the post‐column infusion technique. The proposed methods were successfully applied to the analysis of study rat plasma samples for the simultaneous quantitation of both the dosed drug and its metabolite. The analytical results obtained by the proposed monolithic column methods and the ‘standard’ silica particle‐packed HPLC column method were in good agreement, within 10% error. Copyright © 2002 John Wiley & Sons, Ltd.